Kemi Cui

1.3k total citations
43 papers, 995 citations indexed

About

Kemi Cui is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Kemi Cui has authored 43 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Biomedical Engineering. Recurrent topics in Kemi Cui's work include 3D Printing in Biomedical Research (7 papers), Computational Drug Discovery Methods (7 papers) and Acupuncture Treatment Research Studies (6 papers). Kemi Cui is often cited by papers focused on 3D Printing in Biomedical Research (7 papers), Computational Drug Discovery Methods (7 papers) and Acupuncture Treatment Research Studies (6 papers). Kemi Cui collaborates with scholars based in United States, China and Japan. Kemi Cui's co-authors include Stephen T.C. Wong, Hong Zhao, Guangxu Jin, Jenny C. Chang, Zhen Zhao, G C Wu, Xiaoping Zhu, Xiaoyin Xu, Xiu Gao and Jin Mo Chung and has published in prestigious journals such as Molecular Cell, Cancer Research and Scientific Reports.

In The Last Decade

Kemi Cui

38 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kemi Cui United States 20 491 221 123 118 117 43 995
Huisheng Wang China 18 940 1.9× 297 1.3× 35 0.3× 115 1.0× 237 2.0× 56 1.4k
Zeqiu Han United States 18 522 1.1× 153 0.7× 73 0.6× 185 1.6× 104 0.9× 24 1.2k
R Rigolio Italy 20 521 1.1× 298 1.3× 39 0.3× 67 0.6× 42 0.4× 39 1.2k
Fang Yuan China 20 534 1.1× 156 0.7× 28 0.2× 52 0.4× 209 1.8× 57 1.2k
Xifu Liu China 16 698 1.4× 360 1.6× 29 0.2× 60 0.5× 61 0.5× 35 1.2k
Zhiyuan Zhu China 19 554 1.1× 125 0.6× 30 0.2× 57 0.5× 340 2.9× 46 1.2k
Gwanghyun Jung United States 15 866 1.8× 130 0.6× 23 0.2× 183 1.6× 58 0.5× 16 1.3k
Xiao Gu China 20 712 1.5× 176 0.8× 40 0.3× 37 0.3× 202 1.7× 40 1.6k
Klaudyna Kojder Poland 12 373 0.8× 330 1.5× 41 0.3× 52 0.4× 227 1.9× 29 1.2k
Jun Cai United Kingdom 20 788 1.6× 194 0.9× 13 0.1× 132 1.1× 248 2.1× 45 1.4k

Countries citing papers authored by Kemi Cui

Since Specialization
Citations

This map shows the geographic impact of Kemi Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemi Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemi Cui more than expected).

Fields of papers citing papers by Kemi Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemi Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemi Cui. The network helps show where Kemi Cui may publish in the future.

Co-authorship network of co-authors of Kemi Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Kemi Cui. A scholar is included among the top collaborators of Kemi Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemi Cui. Kemi Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Kemi, Hong Peng, Jie Lin, et al.. (2025). Hope and challenges in the diagnosis and treatment of Wilms tumor: a single-center retrospective study in China. Frontiers in Pediatrics. 13. 1527039–1527039.
2.
Zhu, Fengzhao, Kemi Cui, Xing Liu, et al.. (2025). An updated systematic review and meta-analysis on the efficacy of supine versus prone position for pediatric PCNL. International Urology and Nephrology. 57(8). 2345–2358.
4.
Cui, Kemi, Hong Peng, Jie Lin, et al.. (2025). Treatment and prognosis of pelvic-related urethral injuries in children: a 20-year single-center study and systematic review. BMC Pediatrics. 25(1). 277–277.
5.
6.
Huang, Lei, Sarah G. Injac, Kemi Cui, et al.. (2018). Systems biology–based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma. Science Translational Medicine. 10(464). 45 indexed citations
7.
Zheng, Ze‐Yi, Jing Li, Fuhai Li, et al.. (2018). Induction of N-Ras degradation by flunarizine-mediated autophagy. Scientific Reports. 8(1). 16932–16932. 12 indexed citations
8.
Zhao, Zhen, Xiaoping Zhu, Kemi Cui, et al.. (2016). In Vivo Visualization and Characterization of Epithelial–Mesenchymal Transition in Breast Tumors. Cancer Research. 76(8). 2094–2104. 65 indexed citations
9.
Lü, Yan, Haijun Zhao, Yuan Wang, et al.. (2015). Electro-acupuncture up-regulates astrocytic MCT1 expression to improve neurological deficit in middle cerebral artery occlusion rats. Life Sciences. 134. 68–72. 23 indexed citations
10.
Zhao, Hong, Guangxu Jin, Kemi Cui, et al.. (2013). Novel Modeling of Cancer Cell Signaling Pathways Enables Systematic Drug Repositioning for Distinct Breast Cancer Metastases. Cancer Research. 73(20). 6149–6163. 28 indexed citations
11.
Liu, Timothy, Ding Ren, Xiaoping Zhu, et al.. (2013). Transcriptional signaling pathways inversely regulated in Alzheimer's disease and glioblastoma multiform. Scientific Reports. 3(1). 33 indexed citations
12.
Jin, Guangxu, et al.. (2011). A Novel Method of Transcriptional Response Analysis to Facilitate Drug Repositioning for Cancer Therapy. Cancer Research. 72(1). 33–44. 61 indexed citations
13.
Yang, Chunying, Xi Tang, Xiaojing Guo, et al.. (2011). Aurora-B Mediated ATM Serine 1403 Phosphorylation Is Required for Mitotic ATM Activation and the Spindle Checkpoint. Molecular Cell. 44(4). 597–608. 93 indexed citations
14.
Wong, Kelvin, Geoffrey S. Young, Milan Makale, et al.. (2011). Characterization of a human tumorsphere glioma orthotopic model using magnetic resonance imaging. Journal of Neuro-Oncology. 104(2). 473–481. 19 indexed citations
15.
Zhao, Hong, Kemi Cui, Fang Nie, et al.. (2011). The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models. Breast Cancer Research and Treatment. 131(2). 425–436. 40 indexed citations
16.
Li, Hai, Zhong Xue, Kemi Cui, & Stephen T.C. Wong. (2010). Diffusion tensor-based fast marching for modeling human brain connectivity network. Computerized Medical Imaging and Graphics. 35(3). 167–178. 9 indexed citations
17.
Cui, Kemi, et al.. (2009). Bushen Ningxin Decoction pharmacological serum promotes the proliferation and suppresses the apoptosis of murine osteoblasts through MAPK pathway. Journal of Ethnopharmacology. 122(2). 221–226. 19 indexed citations
18.
Cui, Kemi, Xiaoyin Xu, Hong Zhao, & Stephen T.C. Wong. (2008). A quantitative study of factors affecting in vivo bioluminescence imaging. Luminescence. 23(5). 292–295. 32 indexed citations
19.
Mao‐Ying, Qi‐Liang, Kemi Cui, Qiong Liu, et al.. (2005). Stage‐dependent analgesia of electro‐acupuncture in a mouse model of cutaneous cancer pain. European Journal of Pain. 10(8). 689–689. 27 indexed citations
20.
Cui, Kemi, et al.. (2004). Electro-acupuncture relieves chronic visceral hyperalgesia in rats. Neuroscience Letters. 376(1). 20–23. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026